Cure My Disease

Don't miss your cure!

 Log in / Sign up

Lip reading lessons boost hearing aid Users' speech skills?

NCT ID NCT07028658

Symptom relief Sponsor: Institut Pasteur Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now This study
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tests if lip reading rehabilitation improves how well people with hearing aids can recognize spoken words by watching a speaker's mouth. Eight adults with moderate to severe hearing loss will participate. The goal is to see if this therapy helps them understand speech better, especially in noisy situations.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Participants

About 8 people

The number the study aims to enrol. It can still change while the study runs.

Started

Oct 2025

Expected to finish

Sep 2026

An estimate. End dates often move.

Lead sponsor

A company

The lead sponsor is a pharmaceutical, biotech, or medical-device company.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Who is studied

The study population consists of hearing-impaired individuals with hearing aids

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Patient aged 18 or older * Affiliated with a social security system * Moderate to severe bilateral post-lingual hearing loss, fitted with hearing aids for more than 6 months * Wearing hearing aids for a minimum of 8 hours/day on average over the past month * Intelligibility in quiet \> 80% correct responses at 60 dB (Lafon cochlear list) * Difficulty in noisy environments rated \> 6 on a 0-10 EVA scale * French language comprehension level of at least B1 CEFR (Common European Framework of Reference for Languages) * Willing to participate in speech therapy rehabilitation at a rate of 2 sessions per week Exclusion Criteria: * Patient who has already undergone speech therapy rehabilitation as part of their hearing loss treatment * Diagnosis of neurodegenerative disease or history of brain injury (traumatic brain injury, stroke, tumor, meningitis, etc.) * Uncorrected vision or visual impairment affecting lip reading (e.g. AMD, glaucoma, unoperated cataract, etc.) * Presence of severe tinnitus (score \> 56) on the Tinnitus Handicap Inventory (THI) questionnaire * Significant cognitive impairment (CODEX C or D) or Montreal Cognitive Assessment (MOCA) score \< 23

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Hearing loss, bilateral or unilateral are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

hearing loss disorder

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Hearing loss, bilateral or unilateral

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    1 site. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • Cabinet d'orthophonie

    RECRUITING

    Paris, 75008, France

More trials for these conditions

Other studies related to the condition(s) this trial covers.